Key Account Manager, Biosimilars (Belgium) at IQVIA

Brussels, Brussels, Belgium

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree in Life Sciences or related field
Proficient in Dutch, English, and ideally French
Minimum 5 years’ experience in pharmaceutical market access or sales, preferably with biosimilars or specialty care
Experience in biosimilars or therapy areas such as Rare Disease, Haematology, Nephrology, Immunology, Oncology, Endocrinology, Orthopaedics, or Rheumatology
Deep knowledge of healthcare systems at national and local levels
Proven ability to open new markets and drive access strategy
Excellent communication, negotiation, and relationship-building skills

Responsibilities

Develop and execute a regional access and sales strategy aligned with company goals
Build strong relationships with key accounts, prescribers, and healthcare decision-makers
Identify target customers through maintaining and analyzing customer records
Produce an appropriate territory business plan
Educate target audiences on the value proposition of our biosimilar product portfolio
Identify access barriers and develop tailored solutions to gain market entry and drive adoption
Utilize CRM and planning tools to track progress and optimize outreach
Monitor competitor activity and adjust strategy accordingly
Lead local market access initiatives and support internal teams with training and market insights

Skills

Market Access

Sales Strategy

CRM

Negotiation

Relationship Building

Stakeholder Engagement

Competitor Analysis

Territory Management

Biosimilars

Dutch

English

French

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free